Follow
Hamdi Jama
Hamdi Jama
Research fellow, Monash University
Verified email at monash.edu
Title
Cited by
Cited by
Year
Deficiency of prebiotic fiber and insufficient signaling through gut metabolite-sensing receptors leads to cardiovascular disease
DM Kaye, WA Shihata, HA Jama, K Tsyganov, M Ziemann, H Kiriazis, ...
Circulation 141 (17), 1393-1403, 2020
2152020
Microbial peer pressure: the role of the gut microbiota in hypertension and its complications
RR Muralitharan, HA Jama, L Xie, A Peh, M Snelson, FZ Marques
Hypertension 76 (6), 1674-1687, 2020
912020
The effect of diet on hypertensive pathology: is there a link via gut microbiota-driven immunometabolism?
HA Jama, A Beale, WA Shihata, FZ Marques
Cardiovascular Research 115 (9), 1435-1447, 2019
722019
Guidelines for transparency on gut microbiome studies in essential and experimental hypertension
FZ Marques, HA Jama, K Tsyganov, PA Gill, D Rhys-Jones, ...
Hypertension 74 (6), 1279-1293, 2019
702019
The gut microbiota and blood pressure in experimental models
HA Jama, DM Kaye, FZ Marques
Current opinion in nephrology and hypertension 28 (2), 97-104, 2019
572019
Rodent models of hypertension
HA Jama, RR Muralitharan, C Xu, JA O'Donnell, M Bertagnolli, ...
British journal of pharmacology 179 (5), 918-937, 2022
362022
TNF and IL-1 play essential but temporally distinct roles in driving cardiac inflammation in a murine model of Kawasaki disease
AT Stock, HA Jama, JA Hansen, IP Wicks
The Journal of Immunology 202 (11), 3151-3160, 2019
362019
Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial
HA Jama, D Rhys-Jones, M Nakai, CK Yao, RE Climie, Y Sata, ...
Nature Cardiovascular Research 2 (1), 35-43, 2023
312023
Microbial Interventions to Control and Reduce Blood Pressure in Australia (MICRoBIA): rationale and design of a double-blinded randomised cross-over placebo controlled trial
D Rhys-Jones, RE Climie, PA Gill, HA Jama, GA Head, PR Gibson, ...
Trials 22, 1-7, 2021
202021
Renal ACE2 (angiotensin-converting enzyme 2) expression is modulated by dietary fiber intake, gut microbiota, and their metabolites
M Snelson, R R. Muralitharan, E Dinakis, M Nakai, HA Jama, WA Shihata, ...
Hypertension 77 (6), e53-e55, 2021
92021
Manipulation of the gut microbiota by the use of prebiotic fibre does not override a genetic predisposition to heart failure
HA Jama, A Fiedler, K Tsyganov, E Nelson, D Horlock, ME Nakai, ...
Scientific reports 10 (1), 17919, 2020
92020
Population-based gut microbiome associations with hypertension: the need for more detailed phenotypes
H Jama, DM Kaye, FZ Marques
Circulation research 123 (11), 1185-1187, 2018
92018
The Selective Expansion and Targeted Accumulation of Bone Marrow–Derived Macrophages Drive Cardiac Vasculitis
AT Stock, N Collins, GK Smyth, Y Hu, JA Hansen, DB D’Silva, HA Jama, ...
The Journal of Immunology 202 (11), 3282-3296, 2019
82019
Gut microbial metabolites lower 24-hour systolic blood pressure in untreated essential hypertensive patients
HA Jama, D Rhys-Jones, M Nakai, CK Yao, RE Climie, Y Sata, ...
medRxiv, 2022.06. 20.22276673, 2022
52022
Don’t take it with a pinch of salt: how sodium increases blood pressure via the gut microbiota
HA Jama, FZ Marques
Circulation Research 126 (7), 854-856, 2020
52020
Dietary fibre controls blood pressure and cardiovascular risk by lowering large intestinal pH and activating the proton-sensing receptor GPR65
L Xie, D Rhys-Jones, RR Muralitharan, E Dinakis, M Nakai, M Paterson, ...
bioRxiv, 2022.11. 17.516695, 2022
42022
Maternal diet and gut microbiota influence predisposition to cardiovascular disease in the offspring
H Jama, MSI Dona, E Dinakis, M Nakai, MR Paterson, W Shihata, ...
bioRxiv, 2022.03. 12.480450, 2022
32022
GPR41/43 regulates blood pressure by improving gut epithelial barrier integrity to prevent TLR4 activation and renal inflammation
RR Muralitharan, T Zheng, E Dinakis, L Xie, A Barbaro-Wahl, HA Jama, ...
bioRxiv, 2023.03. 20.533376, 2023
22023
DIETARY FIBRE REDUCES INTESTINAL PH AND EXHIBITS CARDIOVASCULAR‐PROTECTIVE EFFECTS THROUGH A PROTON‐SENSING RECEPTOR
L Xie, E Dinakis, R Muralitharan, M Nakai, X Zhang, H Jama, M Paterson, ...
Journal of Hypertension 39, e388, 2021
22021
From hype to hope: Considerations in conducting robust microbiome science
AJ McGuinness, LF Stinson, M Snelson, A Loughman, A Stringer, ...
Brain, Behavior, and Immunity 115, 120-130, 2024
12024
The system can't perform the operation now. Try again later.
Articles 1–20